サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：遺伝子クローニングサービスの世界市場：サービスタイプ別、遺伝子タイプ別、用途別、エンドユーザー別、地域別 - 競合予測・機会（2027年）
市場調査レポート
商品コード
1131713

遺伝子クローニングサービスの世界市場：サービスタイプ別、遺伝子タイプ別、用途別、エンドユーザー別、地域別 - 競合予測・機会（2027年）

Global Gene Cloning Services Market By Service Type, By Gene Type, By Application, By End User, and By Region, Competition Forecast and Opportunities, 2027
出版日: | 発行: TechSci Research | ページ情報: 英文 119 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

遺伝子クローニングサービスの世界市場：サービスタイプ別、遺伝子タイプ別、用途別、エンドユーザー別、地域別 - 競合予測・機会（2027年）
出版日: 2022年10月01日
発行: TechSci Research
ページ情報: 英文 119 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の遺伝子クローニングサービスの市場規模は、2023年から2027年の予測期間中に順調に成長すると予測されています。

市場の成長を後押しする主な要因には、遺伝子合成とクローニングサービスに対する官民からのハイエンドな投資、クローニングとサブクローニングサービスにおける急速な技術的進歩、相乗的サービスの浸透の増加、感染症や慢性疾患の有病率の上昇などが挙げられます。

当レポートでは、世界の遺伝子クローニングサービス市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・課題、サービスタイプ・遺伝子タイプ・用途・エンドユーザー・地域別の分析、および競合情勢などの包括的な情報を提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の遺伝子クローニングサービス市場に対するCOVID-19の影響

第5章 VOC (顧客の声)

  • サービス意識
  • 需要、サービス別
  • 需要、用途別
  • 導入の障壁

第6章 世界の遺伝子クローニングサービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービス別（遺伝子合成サービス、分子生物学サービス、カスタムクローニングサービス、その他）
    • 遺伝子タイプ別（鎖状遺伝子、複合遺伝子、その他）
    • 用途別（遺伝子合成、遺伝子発現、遺伝子治療、ワクチン研究、その他）
    • エンドユーザー別（製薬・バイオテクノロジー企業、臨床研究所、その他）
    • 企業別（2021年）
    • 地域別
  • 製品市場マップ

第7章 北米の遺伝子クローニングサービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 遺伝子タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米：国別の分析
    • 米国の遺伝子クローニングサービス市場の見通し
    • メキシコの遺伝子クローニングサービス市場の見通し
    • カナダの遺伝子クローニングサービス市場の見通し

第8章 欧州の遺伝子クローニングサービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 遺伝子タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州：国別分析
    • フランスの遺伝子クローニングサービス市場の見通し
    • ドイツの遺伝子クローニングサービス市場の見通し
    • 英国の遺伝子クローニングサービス市場の見通し
    • イタリアの遺伝子クローニングサービス市場の見通し
    • スペインの遺伝子クローニングサービス市場の見通し

第9章 アジア太平洋の遺伝子クローニングサービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 遺伝子タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋：国別の分析
    • 中国の遺伝子クローニングサービス市場の見通し
    • インドの遺伝子クローニングサービス市場の見通し
    • 韓国の遺伝子クローニングサービス市場の見通し
    • 日本の遺伝子クローニングサービス市場の見通し
    • オーストラリアの遺伝子クローニングサービス市場の見通し

第10章 南米の遺伝子クローニングサービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 遺伝子タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米：国別の分析
    • ブラジルの遺伝子クローニングサービス市場の見通し
    • アルゼンチンの遺伝子クローニングサービス市場の見通し
    • コロンビアの遺伝子クローニングサービス市場の見通し

第11章 中東・アフリカの遺伝子クローニングサービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 遺伝子タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 中東・アフリカ：国別の分析
    • 南アフリカの遺伝子クローニングサービス市場の見通し
    • サウジアラビアの遺伝子クローニングサービス市場の見通し
    • アラブ首長国連邦の遺伝子クローニングサービス市場の見通し

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と発展

第14章 競合情勢

  • Thermo Fischer Scientific, Inc.
  • Eurofins Scientific SE
  • Genscript Biotech Corp
  • Merck KGaA
  • Takara Bio Inc.
  • Charles River Laboratories International, Inc.
  • Sartorius AG
  • Cellecta, Inc.
  • Creative Biogene, Inc.
  • Biocompare, Inc.

第15章 戦略的提言

目次
Product Code: 11781

The global gene cloning services market is anticipated to have robust growth in the forecast period, 2023-2027. The growth of the market is attributed to the high-end investments by the public and private players for gene synthesis and cloning services and rapid technological advancements in cloning and sub-cloning services. Increased penetration of synergistic services in the market and the rise in prevalence of infectious and chronic diseases are the other two prominent factors that are expected to boost the demand for the global gene cloning services market over the next five years.

Advantages of using Gene Cloning Services Drives the Market Growth

Gene cloning is expected to transform the medical industry and the biological field. The major advantages of using gene cloning services include analyzing the effect of mutation on a particular gene and making proteins with biomedical techniques. Gene cloning is used to develop recombinant versions of the non-functional gene to understand the functioning of the normal gene. Several specialized providers are providing gene cloning services to interested end users. Generally, the end users prefer to outsource these applications, which not only saves time and effort but also provides technical expertise and facilities dedicated to different molecular cloning and subcloning procedures. Gene cloning services the benefits of fast delivery and several options in select markets and vector types. Researchers and biotechnology companies are expected to benefit from the emergence of gene cloning services as they quickly generate the desired constructs with 100% accuracy, which allows focusing the end users on other critical steps for research. Therefore, with the rapidly developing biomedical field, the demand for the global gene cloning services market is expected to grow at a significant rate over the next five years.

Increased prevalence of Chronic Diseases Favors the Market Growth

There has been a rise in the occurrence of chronic and lifestyle-related disorders due to the adoption of unhealthy eating habits and sedentary lifestyles among consumers. They are spending less time on physical activities, which is deteriorating their health and giving rise to a number of diseases that can harm their health and sometimes even take the lives of an individual. There has been a constant increase in the demand for the development of effective drugs and disease treatment processes. Cloning can be beneficial in the drug discovery and development process. They are used to identify specific genetic variations to target different therapeutic compounds. Gene cloning services can also be used for the development of vaccines as they help researchers and pharmaceutical companies to study detail about genes and identify receptor subtypes. Gene cloning is also used for the creation of insulin or human growth hormones. Also, their use in gene therapy to treat or prevent disease by correcting the underlying genetic problem is influencing the market demand. The various applications of gene cloning in the biomedical field are expected to fuel the global gene cloning services market demand over the next five years.

Market Segmentation

The global gene cloning services market is segmented into service type, gene type, application, end user, regional distribution, and competitive landscape. Based on service type, the market is divided into gene synthesis service, molecular biology service, custom cloning service, and others. Based on gene type, the market is divided into stranded gene, complex gene, and others. Based on application, the market is divided into gene synthesis, gene expression, gene therapy, vaccine research, and others. Based on end user, the market is divided into pharmaceutical & biotechnology companies, clinical laboratories, and others. The market analysis also studies the regional, which is divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region. In terms of country, the United States is expected to hold a significant market share over the forecast period. The presence of well-developed healthcare infrastructure and high-end investments by the leading authorities in research and development activities are driving the market demand in the country.

Market Players

Thermo Fischer Scientific, Inc., Eurofins Scientific SE, Genscript Biotech Corp, Merck KGaA, Takara Bio Inc., Charles River Laboratories International, Inc., Sartorius AG, Cellecta, Inc., Creative Biogene, Inc., Biocompare, Inc. are the major market players operating in the global gene cloning services market.

Report Scope:

In this report, global gene cloning services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Gene Cloning Services Market, By Service Type:

  • Gene Synthesis Service
  • Molecular Biology Service
  • Custom Cloning Service
  • Others

Gene Cloning Services Market, By Gene Type:

  • Stranded Gene
  • Complex Gene
  • Others

Gene Cloning Services Market, By Application:

  • Gene Synthesis
  • Gene Expression
  • Gene Therapy
  • Vaccine Research
  • Others

Gene Cloning Services Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Clinical Laboratories
  • Others

Gene Cloning Services Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global gene cloning services market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Gene Cloning Services Market

5. Voice of Customer

  • 5.1. Service Awareness
  • 5.2. Demand, By Service
  • 5.3. Demand, By Application
  • 5.4. Barriers to Adoption

6. Global Gene Cloning Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service Type (Gene Synthesis Service, Molecular Biology Service, Custom Cloning Service, Others)
    • 6.2.2. By Gene Type (Stranded Gene, Complex Gene, Others)
    • 6.2.3. By Application (Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research, Others)
    • 6.2.4. By End User (Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. North America Gene Cloning Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service Type
    • 7.2.2. By Gene Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Gene Cloning Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service Type
        • 7.3.1.2.2. By Gene Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Gene Cloning Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service Type
        • 7.3.2.2.2. By Gene Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Gene Cloning Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service Type
        • 7.3.3.2.2. By Gene Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Gene Cloning Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service Type
    • 8.2.2. By Gene Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Gene Cloning Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service Type
        • 8.3.1.2.2. By Gene Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Gene Cloning Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service Type
        • 8.3.2.2.2. By Gene Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Gene Cloning Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service Type
        • 8.3.3.2.2. By Gene Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Gene Cloning Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service Type
        • 8.3.4.2.2. By Gene Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Gene Cloning Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service Type
        • 8.3.5.2.2. By Gene Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Gene Cloning Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service Type
    • 9.2.2. By Gene Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Gene Cloning Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service Type
        • 9.3.1.2.2. By Gene Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Gene Cloning Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service Type
        • 9.3.2.2.2. By Gene Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Korea Gene Cloning Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service Type
        • 9.3.3.2.2. By Gene Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. Japan Gene Cloning Services Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Service Type
        • 9.3.4.2.2. By Gene Type
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Gene Cloning Services Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Service Type
        • 9.3.5.2.2. By Gene Type
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Gene Cloning Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service Type
    • 10.2.2. By Gene Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gene Cloning Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service Type
        • 10.3.1.2.2. By Gene Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Gene Cloning Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service Type
        • 10.3.2.2.2. By Gene Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Gene Cloning Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service Type
        • 10.3.3.2.2. By Gene Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Gene Cloning Services Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Service Type
    • 11.2.2. By Gene Type
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Gene Cloning Services Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Service Type
        • 11.3.1.2.2. By Gene Type
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Gene Cloning Services Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Service Type
        • 11.3.2.2.2. By Gene Type
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Gene Cloning Services Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Service Type
        • 11.3.3.2.2. By Gene Type
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

  • 14.1. Thermo Fischer Scientific, Inc.
  • 14.2. Eurofins Scientific SE
  • 14.3. Genscript Biotech Corp
  • 14.4. Merck KGaA
  • 14.5. Takara Bio Inc.
  • 14.6. Charles River Laboratories International, Inc.
  • 14.7. Sartorius AG
  • 14.8. Cellecta, Inc.
  • 14.9. Creative Biogene, Inc.
  • 14.10. Biocompare, Inc.

15. Strategic Recommendations